662 related articles for article (PubMed ID: 19326415)
1. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
Thin L; Macquillan G; Adams L; Garas G; Seow C; Cannell P; Augustson B; Mitchell A; Delriveire L; Jeffrey G
Liver Transpl; 2009 Apr; 15(4):421-6. PubMed ID: 19326415
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
3. Chronic graft-versus-host disease after liver transplantation: a case report.
Yilmaz M; Ozdemir F; Akbulut S; Ersan V; Koc C; Koc S; Yilmaz S
Transplant Proc; 2012; 44(6):1751-3. PubMed ID: 22841262
[TBL] [Abstract][Full Text] [Related]
4. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
Piton G; Larosa F; Minello A; Becker MC; Mantion G; Aubin F; Deconinck E; Hillon P; Di Martino V
Liver Transpl; 2009 Jul; 15(7):682-5. PubMed ID: 19562700
[TBL] [Abstract][Full Text] [Related]
5. Etanercept in graft-versus-host disease.
Andolina M; Rabusin M; Maximova N; Di Leo G
Bone Marrow Transplant; 2000 Oct; 26(8):929. PubMed ID: 11081399
[No Abstract] [Full Text] [Related]
6. Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation.
Whalen JG; Jukic DM; English JC
J Am Acad Dermatol; 2005 May; 52(5):908-12. PubMed ID: 15858489
[TBL] [Abstract][Full Text] [Related]
7. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.
Carroll MB; Bond MI
Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983
[TBL] [Abstract][Full Text] [Related]
8. Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD.
Faraci M; Lanino E; Morreale G; Giardino S; Fossati M; Moroni C; Caviglia I; Castagnola E
Bone Marrow Transplant; 2011 Jan; 46(1):159-60. PubMed ID: 20383214
[No Abstract] [Full Text] [Related]
9. Acute graft versus host disease following living donor liver transplantation: first Korean report.
Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
[TBL] [Abstract][Full Text] [Related]
10. Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
Uberti JP; Ayash L; Ratanatharathorn V; Silver S; Reynolds C; Becker M; Reddy P; Cooke KR; Yanik G; Whitfield J; Jones D; Hutchinson R; Braun T; Ferrara JL; Levine JE
Biol Blood Marrow Transplant; 2005 Sep; 11(9):680-7. PubMed ID: 16125638
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies.
Tsimberidou AM; Giles FJ
Expert Rev Anticancer Ther; 2002 Jun; 2(3):277-86. PubMed ID: 12113051
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host disease after liver transplantation: successful treatment of a case.
Lu Y; Wu LQ; Zhang BY; Cao JY
Transplant Proc; 2008 Dec; 40(10):3784-6. PubMed ID: 19100490
[TBL] [Abstract][Full Text] [Related]
13. Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept.
Wolff D; Roessler V; Steiner B; Wilhelm S; Weirich V; Brenmoehl J; Leithaeuser M; Hofmeister N; Junghanss C; Casper J; Hartung G; Holler E; Freund M
Bone Marrow Transplant; 2005 May; 35(10):1003-10. PubMed ID: 15806135
[TBL] [Abstract][Full Text] [Related]
14. [Graft versus host disease after liver transplantation: a report of 3 cases].
Liang TB; Tang XF; Zheng SS; Lu AW; Wang WL; Shen Y; Zhang M; Meng XQ
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):826-9. PubMed ID: 15200885
[TBL] [Abstract][Full Text] [Related]
15. Early Use of Etanercept for Graft-Versus-Host Disease After Liver Transplant: the Importance of Broad Spectrum Infective Prophylaxis.
Boscolo A; Menin E; Zelaschi B; Albertoni L; Zanus G; Baratto F
Exp Clin Transplant; 2020 Feb; 18(1):123-127. PubMed ID: 29619911
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment for graft-versus-host disease after liver transplantation: two case reports.
Wang B; Lu Y; Yu L; Liu C; Wu Z; Liu X
Transplant Proc; 2007 Jun; 39(5):1696-8. PubMed ID: 17580224
[TBL] [Abstract][Full Text] [Related]
17. Etanercept in psoriasis treatment.
Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
[TBL] [Abstract][Full Text] [Related]
18. Treatment of liver transplant graft-versus-host disease with antibodies against tumor necrosis factor-α.
Blank G; Li J; Kratt T; Handgretinger R; Königsrainer A; Nadalin S
Exp Clin Transplant; 2013 Feb; 11(1):68-71. PubMed ID: 23387543
[TBL] [Abstract][Full Text] [Related]
19. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
Collazo MH; González JR; Torres EA
P R Health Sci J; 2008 Dec; 27(4):346-7. PubMed ID: 19069362
[TBL] [Abstract][Full Text] [Related]
20. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
Ward SC; Chang CY; Peng L; Liu LU
Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
